ECG monitoring of treatment response in pulmonary arterial hypertension patients

I.R. Henkens; C.T. Gan; S.A. van Wolferen; M. Hew; A. Boonstra; J.W.R. Twisk; O. Kamp; E.E. van der Wall; M.J. Schalij; A. Vonk Noordegraaf; H.W. Vliegen; Tji-Joong Gan

doi:https://doi.org/10.1378/chest.08-0461

ECG monitoring of treatment response in pulmonary arterial hypertension patients

I.R. Henkens, C.T. Gan, S.A. van Wolferen, M. Hew, A. Boonstra, J.W.R. Twisk, O. Kamp, E.E. van der Wall, M.J. Schalij, A. Vonk Noordegraaf, H.W. Vliegen, Tji-Joong Gan

Research output: Contribution to journal › Article › Academic › peer-review

42 Citations (Scopus)

Abstract

Background: The potential use of the ECG for monitoring treatment effects in patients with pulmonary arterial hypertension (PAH) has not been investigated. We evaluated whether the ECG is useful for monitoring treatment response based on changes in pulmonary vascular resistance (PVR). Methods: An ECG was recorded in 81 PAH patients at the time of diagnostic right heart catheterization and after 1 year of treatment. Patients were treated according to the guidelines. Patients were divided into two groups based on PVR (ie, < 500 or > 500 dyne · s · cm

Original language	English
Pages (from-to)	1250-1257
Journal	Chest
Volume	134
Issue number	6
DOIs	https://doi.org/10.1378/chest.08-0461
Publication status	Published - 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

https://doi.org/10.1378/chest.08-0461

Cite this

@article{6a834a3732904bf39e7f650e0da40ceb,

title = "ECG monitoring of treatment response in pulmonary arterial hypertension patients",

abstract = "Background: The potential use of the ECG for monitoring treatment effects in patients with pulmonary arterial hypertension (PAH) has not been investigated. We evaluated whether the ECG is useful for monitoring treatment response based on changes in pulmonary vascular resistance (PVR). Methods: An ECG was recorded in 81 PAH patients at the time of diagnostic right heart catheterization and after 1 year of treatment. Patients were treated according to the guidelines. Patients were divided into two groups based on PVR (ie, < 500 or > 500 dyne · s · cm",

author = "I.R. Henkens and C.T. Gan and {van Wolferen}, S.A. and M. Hew and A. Boonstra and J.W.R. Twisk and O. Kamp and {van der Wall}, E.E. and M.J. Schalij and {Vonk Noordegraaf}, A. and H.W. Vliegen and Tji-Joong Gan",

year = "2008",

doi = "https://doi.org/10.1378/chest.08-0461",

language = "English",

volume = "134",

pages = "1250--1257",

journal = "Chest",

issn = "0012-3692",

publisher = "American College of Chest Physicians",

number = "6",

}

TY - JOUR

T1 - ECG monitoring of treatment response in pulmonary arterial hypertension patients

AU - Henkens, I.R.

AU - Gan, C.T.

AU - van Wolferen, S.A.

AU - Hew, M.

AU - Boonstra, A.

AU - Twisk, J.W.R.

AU - Kamp, O.

AU - van der Wall, E.E.

AU - Schalij, M.J.

AU - Vonk Noordegraaf, A.

AU - Vliegen, H.W.

AU - Gan, Tji-Joong

PY - 2008

Y1 - 2008

N2 - Background: The potential use of the ECG for monitoring treatment effects in patients with pulmonary arterial hypertension (PAH) has not been investigated. We evaluated whether the ECG is useful for monitoring treatment response based on changes in pulmonary vascular resistance (PVR). Methods: An ECG was recorded in 81 PAH patients at the time of diagnostic right heart catheterization and after 1 year of treatment. Patients were treated according to the guidelines. Patients were divided into two groups based on PVR (ie, < 500 or > 500 dyne · s · cm

AB - Background: The potential use of the ECG for monitoring treatment effects in patients with pulmonary arterial hypertension (PAH) has not been investigated. We evaluated whether the ECG is useful for monitoring treatment response based on changes in pulmonary vascular resistance (PVR). Methods: An ECG was recorded in 81 PAH patients at the time of diagnostic right heart catheterization and after 1 year of treatment. Patients were treated according to the guidelines. Patients were divided into two groups based on PVR (ie, < 500 or > 500 dyne · s · cm

U2 - https://doi.org/10.1378/chest.08-0461

DO - https://doi.org/10.1378/chest.08-0461

M3 - Article

C2 - 18641107

SN - 0012-3692

VL - 134

SP - 1250

EP - 1257

JO - Chest

JF - Chest

IS - 6

ER -